Literature DB >> 32877537

The Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS Program's Response to the Opioid Epidemic.

Nicole S Chavis1, Pamela W Klein1, Stacy M Cohen1, Antigone Dempsey1, Heather Hauck2, Laura W Cheever2.   

Abstract

BACKGROUND: The United States is in the midst of an unprecedented opioid crisis with increasing injection drug use (IDU)-related human immunodeficiency virus (HIV) outbreaks, particularly in rural areas. The Health Resources and Services Administration (HRSA)'s Ryan White HIV/AIDS Program (RWHAP) is well positioned to integrate treatment for IDU-associated HIV infections with treatment for drug use disorders. These activities will be crucial for the "Ending the HIV Epidemic: A Plan for America" (EHE) initiative, in which 7 southern states were identified with rural HIV epidemics.
METHODS: The RWHAP Services Report data were used to assess the IDU population and substance use services utilization among RWHAP clients in 2017, nationally and in the 7 EHE-identified states. THe HRSA held a 1-day Technical Expert Panel (TEP) to explore how RWHAP can best respond to the growing opioid crisis.
RESULTS: During the TEP, 8 key themes emerged and 11 best practices were identified to address opioid use disorder (OUD) among people with HIV. In 2017, among RWHAP clients with reported age and transmission category, 6.7% (31 683) had HIV attributed to IDU; among IDU clients, 6.3% (1988) accessed substance use services.
CONCLUSIONS: The TEP results and RWHAP data were used to develop implementation science projects that focus on addressing OUD and integrating behavioral health in primary care. These activities are critical to ending the HIV epidemic. Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Entities:  

Keywords:  HIV; RWHAP; injection drug use; opioid; rural

Mesh:

Year:  2020        PMID: 32877537     DOI: 10.1093/infdis/jiaa230

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Access to Medications for Opioid Use Disorder for Persons With Human Immunodeficiency Virus in the United States: Gaps in Coverage by State AIDS Drug Assistance Programs.

Authors:  Kathleen A McManus; Thibaut Davy-Mendez; Amy Killelea; Asher J Schranz
Journal:  Open Forum Infect Dis       Date:  2022-03-07       Impact factor: 4.423

2.  Coordinating Systems of Care for HIV and Opioid Use Disorder: A Systematic Review of Enablers and Barriers to Integrated Service Access, and Systems and Tools Required for Implementation.

Authors:  Malia Duffy; Anna Ghosh; Ana Geltman; Gabriel Kieto Mahaniah; Molly Higgins-Biddle; Michele Clark
Journal:  Med Care Res Rev       Date:  2021-10-11       Impact factor: 2.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.